相似文献
1
Indian Council of Medical Research consensus document for the management of colorectal cancer.
Indian J Med Paediatr Oncol. 2014 Jul;35(3):192-6. doi: 10.4103/0971-5851.142031.
2
Indian Council of Medical Research consensus document for the management of buccal mucosa cancer.
Indian J Med Paediatr Oncol. 2014 Apr;35(2):136-9. doi: 10.4103/0971-5851.138953.
3
Indian Council of Medical Research consensus document on hepatocellular carcinoma.
Indian J Med Res. 2020 Nov;152(5):468-474. doi: 10.4103/ijmr.IJMR_404_20.
4
Indian Council of Medical Research consensus document for the management of gastric cancer.
Indian J Med Paediatr Oncol. 2014 Oct;35(4):239-43. doi: 10.4103/0971-5851.144970.
5
Indian Council of Medical Research Consensus Document for the Management of Non-Hodgkin's Lymphoma (High Grade).
Indian J Med Paediatr Oncol. 2017 Jan-Mar;38(1):51-58. doi: 10.4103/0971-5851.203500.
6
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.
Eur J Cancer. 2014 Jan;50(1):1.e1-1.e34. doi: 10.1016/j.ejca.2013.06.048. Epub 2013 Oct 31.
7
Adaptation of 2016 European Society of Cardiology/European Atherosclerosis Society guideline for lipid management to Indian patients - A consensus document.
Indian Heart J. 2018 Sep-Oct;70(5):736-744. doi: 10.1016/j.ihj.2018.03.011. Epub 2018 Jul 18.
8
Indian Council of Medical Research consensus document for the management of gall bladder cancer.
Indian J Med Paediatr Oncol. 2015 Apr-Jun;36(2):79-84. doi: 10.4103/0971-5851.158829.
9
Indian Council of Medical Research consensus document for the management of tongue cancer.
Indian J Med Paediatr Oncol. 2015 Jul-Sep;36(3):140-5. doi: 10.4103/0971-5851.166712.
10
Management of Hepatoblastoma: ICMR Consensus Document.
Indian J Pediatr. 2017 Jun;84(6):456-464. doi: 10.1007/s12098-017-2301-9. Epub 2017 Mar 29.
引用本文的文献
1
A randomized phase II/III trial of rosuvastatin with neoadjuvant chemo-radiation in patients with locally advanced rectal cancer.
Front Oncol. 2025 Mar 19;15:1450602. doi: 10.3389/fonc.2025.1450602. eCollection 2025.
2
Assessing neoadjuvant therapy recommendations in 19 national and international guidelines for rectal cancer.
Tech Coloproctol. 2024 Aug 5;28(1):94. doi: 10.1007/s10151-024-02969-5.
3
Utility of immunohistochemical expression of E-cadherin in colorectal carcinoma.
Prz Gastroenterol. 2022;17(1):59-66. doi: 10.5114/pg.2021.107801. Epub 2021 Jul 14.
4
Activation of Epithelial-Mesenchymal Transition and Altered β-Catenin Signaling in a Novel Indian Colorectal Carcinoma Cell Line.
Front Oncol. 2019 Feb 15;9:54. doi: 10.3389/fonc.2019.00054. eCollection 2019.
5
Is Colorectal Cancer in Young (<40 Years) Different from those in the Elderly (>40 Years): Experience from a Regional Care Center.
Indian J Med Paediatr Oncol. 2017 Oct-Dec;38(4):466-470. doi: 10.4103/ijmpo.ijmpo_187_16.
6
Mesenchymal stromal cells as regulators of anti-tumour immune response.
Indian J Med Res. 2015 Feb;141(2):139-42. doi: 10.4103/0971-5916.155530.
本文引用的文献
1
The relation between pathological complete response and clinical outcome in patients with rectal cancer.
Hepatogastroenterology. 2013 Sep;60(126):1365-70.
2
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.
Lancet Oncol. 2012 Jun;13(6):579-88. doi: 10.1016/S1470-2045(12)70116-X. Epub 2012 Apr 13.
3
The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Health Technol Assess. 2011 Sep;15(35):1-192, iii-iv. doi: 10.3310/hta15350.
4
Indications and techniques of transanal endoscopic microsurgery (TEMS).
J Gastrointest Surg. 2011 Aug;15(8):1306-8. doi: 10.1007/s11605-011-1576-9. Epub 2011 Jun 7.
5
Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.
J Clin Oncol. 2011 Apr 10;29(11):1465-71. doi: 10.1200/JCO.2010.33.6297. Epub 2011 Mar 7.
6
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
J Clin Oncol. 2010 Jul 10;28(20):3219-26. doi: 10.1200/JCO.2009.27.1825. Epub 2010 May 24.
7
Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis.
Eur J Cancer. 2010 Apr;46(6):1049-55. doi: 10.1016/j.ejca.2010.01.020.
8
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
Lancet Oncol. 2010 Jan;11(1):38-47. doi: 10.1016/S1470-2045(09)70330-4. Epub 2009 Nov 26.
9
Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.
J Nucl Med. 2009 Jul;50(7):1036-41. doi: 10.2967/jnumed.109.063040. Epub 2009 Jun 12.
10
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.
J Clin Oncol. 2009 Jul 1;27(19):3109-16. doi: 10.1200/JCO.2008.20.6771. Epub 2009 May 18.
Zotero 插件